Details of the Drug

General Information of Drug (ID: DMJINLQ)

Drug Name

FPT155

Indication

Disease Entry	ICD 11	Status	REF
Solid tumour/cancer	2A00-2F9Z	Phase 1	[1]
------------------------------------------------------------------------------------

Drug Type

Recombinant protein

Cross-matching ID

References

1	ClinicalTrials.gov (NCT04074759) FPT155 in Patients With Advanced Solid Tumors (FPT155-001). U.S. National Institutes of Health.